Compare
Intuitive Surgical Inc vs Zimmer Biomet Holdings, Inc. vs Edwards Lifesciences Corp vs Steris PLC
| Latest fiscal year | Intuitive Surgical Inc ISRG | Zimmer Biomet Holdings, Inc. ZBH | Edwards Lifesciences Corp EW | Steris PLC STE |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-03-31 |
| Revenue | $10.06B | $8.23B | $6.07B | $5.94B |
| Revenue growth (YoY) | +20.5% | +7.2% | +11.5% | +8.7% |
| Gross margin | 66.0% | n/a | 78.0% | 44.2% |
| Operating margin | 29.3% | 13.3% | 20.8% | 18.6% |
| Net margin | 28.4% | 8.6% | 17.6% | 13.2% |
| Net income | $2.86B | $705.10M | $1.07B | $782.30M |
| EPS (Diluted) | $7.87 | $3.55 | $1.83 | $7.93 |
| Operating cash flow | $3.03B | $1.70B | $1.60B | $1.34B |
| Free cash flow | $2.49B | $1.47B | $1.33B | $972.40M |
| Cash & equivalents | $3.37B | $591.90M | $2.94B | n/a |
| Total assets | $20.46B | $23.09B | $13.70B | $10.74B |
| Total liabilities | $2.52B | $10.39B | $3.36B | $3.54B |
| Shareholders' equity | $17.82B | $12.71B | $10.34B | $7.20B |
| Return on year-end equity | 16.0% | 5.5% | 10.3% | 10.9% |
| Shares outstanding | 355.10M | n/a | 580.70M | 97.80M |
Revenue, most recent five fiscal years
| Fiscal year | Intuitive Surgical Inc | Zimmer Biomet Holdings, Inc. | Edwards Lifesciences Corp | Steris PLC |
|---|---|---|---|---|
| Latest | $10.06B Ended 2025-12-31 | $8.23B Ended 2025-12-31 | $6.07B Ended 2025-12-31 | $5.94B Ended 2026-03-31 |
| 1 year earlier | $8.35B Ended 2024-12-31 | $7.68B Ended 2024-12-31 | $5.44B Ended 2024-12-31 | $5.46B Ended 2025-03-31 |
| 2 years earlier | $7.12B Ended 2023-12-31 | $7.39B Ended 2023-12-31 | $5.01B Ended 2023-12-31 | $5.14B Ended 2024-03-31 |
| 3 years earlier | $6.22B Ended 2022-12-31 | $6.94B Ended 2022-12-31 | $4.46B Ended 2022-12-31 | $4.54B Ended 2023-03-31 |
| 4 years earlier | $5.71B Ended 2021-12-31 | $6.83B Ended 2021-12-31 | $5.23B Ended 2021-12-31 | $4.22B Ended 2022-03-31 |